Image showing sections of cerebral brain organoids derived from pluripotent stem cells.
via Agnieszka Rybak-Wolf, MDC/LifeTime
Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime Strategic Research Agenda they now present a roadmap of how to leverage the latest scientific breakthroughs and technologies over the next decade, to track, understand and treat human cells throughout an individual’s lifetime.
The LifeTime initiative, co-coordinated by the Max Delbrück Center of Molecular Medicine in the Helmholtz Association (MDC) in Berlin and the Institut Curie in Paris, has developed a strategy to advance personalized treatment for five major disease classes: cancer, neurological, infectious, chronic inflammatory and cardiovascular diseases. The aim is a new age of personalized, cell-based interceptive medicine for Europe with the potential of improved health outcomes and more cost-effective treatment, resulting in profoundly changing a person’s healthcare experience.
Earlier detection and more effective treatment of diseases
To form a functioning, healthy body, our cells follow developmental paths during which they acquire specific roles in tissues and organs. But when they deviate from their healthy course, they accumulate changes leading to disease which remain undetected until symptoms appear. At this point, medical treatment is often invasive, expensive and inefficient. However, now we have the technologies to capture the molecular makeup of individual cells and to detect the emergence of disease or therapy resistance much earlier.
Using breakthrough single-cell and imaging technologies in combination with artificial intelligence and personalized disease models will allow us to not only predict disease onset earlier, but also to select the most effective therapies for individual patients. Targeting disease-causing cells to intercept disorders before irreparable damage occurs will substantially improve the outlook for many patients and has the potential of saving billions of Euros of disease-related costs in Europe.
A detailed roadmap for implementing LifeTime
The perspective article “The LifeTime initiative and the future of cell-based interceptive medicine in Europe” and the LifeTime Strategic Research Agenda (SRA) explain how these technologies should be rapidly co-developed, transitioned into clinical settings and applied to the five major disease areas. Close interactions between European infrastructures, research institutions, hospitals and industry will be essential to generate, share and analyze LifeTime’s big medical data across European borders. The initiative’s vision advocates ethically responsible research to benefit citizens all across Europe.
According to Professor Nikolaus Rajewsky, scientific director of the Berlin Institute for Medical System Biology at the Max Delbrück Center for Molecular Medicine and coordinator of the LifeTime Initiative, the LifeTime approach is the way into the future: “LifeTime has brought together scientists across fields – from biologists, to clinicians, data scientists, engineers, mathematicians, and physicists – to enable a much improved understanding of molecular mechanisms driving health and disease. Cell-based medicine will allow doctors to diagnose diseases earlier and intercept disorders before irreparable damage has occurred. LifeTime has a unique value proposition that promises to improve the European patient’s health.”
Dr. Geneviève Almouzni, director of research at CNRS, honorary director of the research center from Institut Curie in Paris and co-coordinator of the LifeTime Initiative believes that the future with LifeTime offers major social and economic impact: “By implementing interceptive, cell-based medicine we will be able to considerably improve treatment across many diseases. Patients all over the world will be able to lead longer, healthier lives. The economic impact could be tremendous with billions of Euros saved from productivity gains simply for cancer, and significantly shortened ICU stays for Covid-19. We hope EU leaders will realize we have to invest in the necessary research now.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cell-based interceptive medicine
- Cell phone video technology unveils new method for analyzing walking and gait
Researchers at Kennedy Krieger Institute and Johns Hopkins Medicine have developed a new, accessible approach to analyze a patient's walking ability and stances more effectively. Following numerous ...
- Instructing iPS cell-derived mesenchymal stem cells to inhibit abnormal bone formation in FOP
A team of researchers led by Associate Professor Makoto Ikeya (Department of Clinical Application) has observed early signs of success from providing iPSC-derived mesenchymal stem/stromal cells (iMSCs ...
Go deeper with Google Headlines on:
Cell-based interceptive medicine
[google_news title=”” keyword=”cell-based interceptive medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
LifeTime Initiative
- Nearly 300 Couples Plan to Get Married During Solar Eclipse in Arkansas: 'Once in a Lifetime Experience'
The weddings will be free of charge, with a wedding officiant provided along with decorations, flowers and a wedding cake ...
- Diversity's in the details
Mark Crawford turned down the role as BP's head of diversity, equity and inclusion twice before accepting it, but three years later he's confident he's doing the right thing.
- Clinton Elementary Assistant Principal Abbey Kidwell Gets Surprise of a Lifetime with $25,000 Milken Educator Award
“Congratulations to Ms. Kidwell on representing the state of Tennessee by receiving the prestigious Milken Educator Award,” said Commissioner Lizzette Reynolds. “This well-deserved award is a ...
- ‘Lifetime care’ for race horses is a disgrace – help us call for a hopeful future
Every year, around 13,000 foals are born into the British and Irish racing industries, in the owners’ hope to breed the “next big winner”. Many of these horses will never even see a racecourse. Most ...
- Stc Group celebrates the Inaugural Saudi Green Initiative Day
In alignment with SGI and the Kingdom’s commitment to net-zero by 2060, stc Group has spearheaded carbon reduction program with scientifically derived targets reflective of SGI’s ambitions and its com ...
Go deeper with Google Headlines on:
LifeTime initiative
[google_news title=”” keyword=”LifeTime initiative” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]